Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R L Davis

Showing results (401-410 of 404) with videos related to

Pageof 41
Sort By:
You have reached the last page of results.This site can display upto 404 results.
The New England Journal of Medicine|September 8, 2001
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccineW E Barlow, R L Davis, J W Glasser, et al.
Nature|October 12, 1999
Familial dementia caused by polymerization of mutant neuroserpinR L Davis, A E Shrimpton, P D Holohan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumorsM D Prados, D A Larson, K Lamborn, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Pageof 41

Showing results (401-410 of 404) with videos related to

Sort By:
Pageof 41
You have reached the last page of results.This site can display upto 404 results.
The New England Journal of Medicine|September 8, 2001
The risk of seizures after receipt of whole-cell pertussis or measles, mumps, and rubella vaccineW E Barlow, R L Davis, J W Glasser, et al.
Nature|October 12, 1999
Familial dementia caused by polymerization of mutant neuroserpinR L Davis, A E Shrimpton, P D Holohan, et al.
International Journal of Radiation Oncology, Biology, Physics|January 9, 1998
Radiation therapy and hydroxyurea followed by the combination of 6-thioguanine and BCNU for the treatment of primary malignant brain tumorsM D Prados, D A Larson, K Lamborn, et al.
Clinical Pharmacology and Therapeutics|September 30, 2011
A common 5'-UTR variant in MATE2-K is associated with poor response to metforminJ H Choi, S W Yee, A H Ramirez, et al.
Pageof 41